谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial.

Anne-Laure Sellier-Leclerc,Daniella Magen, Hadas Shasha-Lavsky,Eva Simkova,Arnaud Devresse,Fitsum Guebre-Egziabher,Mini Michael,John C Lieske,Yaacov Frishberg,Sevcan A Bakkaloglu,Chebl Mourani,Rola Saqan,Richard Singer,Isabella Guzzo, Nune Makarova,Richard Willey, Cristin Kaspar,John M Gansner,Jaap W Groothoff

American journal of kidney diseases the official journal of the National Kidney Foundation（2025）

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要